Nuvectis Pharma, Inc. (NVCT) — 8-K Filings

8-K Filings (14)

• 8-K Filing — May 5, 2026
• Nuvectis Pharma Reports Director Changes and Officer Compensation Adjustments — Sep 25, 2025 Risk: medium
  Nuvectis Pharma, Inc. filed an 8-K on September 25, 2025, reporting on the departure of a director, election of a new director, and changes in officer compensat
• Nuvectis Pharma Files 8-K on Financials — Aug 5, 2025 Risk: low
  Nuvectis Pharma, Inc. filed an 8-K on August 5, 2025, reporting on its results of operations and financial condition, and filing financial statements and exhibi
• Nuvectis Pharma Files 8-K on Shareholder Votes — Jun 13, 2025 Risk: low
  Nuvectis Pharma, Inc. filed an 8-K on June 13, 2025, reporting on matters submitted to a vote of security holders as of June 12, 2025. The filing details the co
• Nuvectis Pharma Files 8-K — May 9, 2025 Risk: low
  Nuvectis Pharma, Inc. filed an 8-K on May 9, 2025, reporting other events and financial statements. The filing does not contain specific details on new events,
• Nuvectis Pharma Files 8-K on Operations and Financials — May 6, 2025 Risk: low
  Nuvectis Pharma, Inc. filed an 8-K on May 6, 2025, reporting on its results of operations and financial condition, as well as filing financial statements and ex
• Nuvectis Pharma Files 8-K on Financials — Feb 25, 2025 Risk: low
  Nuvectis Pharma, Inc. filed an 8-K on February 25, 2025, reporting on its Results of Operations and Financial Condition. The filing details financial statements
• Nuvectis Pharma Files 8-K for Material Agreement — Feb 6, 2025 Risk: medium
  On February 5, 2025, Nuvectis Pharma, Inc. entered into a material definitive agreement. The company also reported other events and filed financial statements a
• Nuvectis Pharma Files 8-K on Operations and Financials — Nov 5, 2024 Risk: low
  Nuvectis Pharma, Inc. filed an 8-K on November 5, 2024, reporting on its results of operations and financial condition, as well as financial statements and exhi
• Nuvectis Pharma Files 8-K — Aug 29, 2024 Risk: low
  Nuvectis Pharma, Inc. filed an 8-K on August 29, 2024, reporting other events and financial statements. The filing does not contain specific details about new e
• Nuvectis Pharma Files 8-K on Operations and Financials — Aug 6, 2024 Risk: low
  Nuvectis Pharma, Inc. filed an 8-K on August 6, 2024, reporting on its results of operations and financial condition, as well as financial statements and exhibi
• Nuvectis Pharma Files 8-K on Security Holder Votes — Jun 13, 2024 Risk: low
  Nuvectis Pharma, Inc. filed an 8-K on June 13, 2024, to report on the submission of matters to a vote of its security holders. The filing details the company's
• Nuvectis Pharma Files 8-K on Operations and Financials — May 7, 2024 Risk: low
  Nuvectis Pharma, Inc. filed an 8-K on May 7, 2024, reporting on its results of operations and financial condition, and including financial statements and exhibi
• Nuvectis Pharma Files 8-K on Financials — Mar 5, 2024 Risk: low
  Nuvectis Pharma, Inc. filed an 8-K on March 5, 2024, reporting on its results of operations and financial condition. The filing includes financial statements an

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX